All In Biotech

Drug Trial Radar · NCT07781657

Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of RO7568282 in Participants With Early Symptomatic Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Nov 10, 2026

Primary completion

Nov 1, 2029

Study completion Nov 1, 2029

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Aug 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to compare the effects of RO7568282 versus a placebo in people in the early stages of Alzheimer's disease (AD).

Conditions

  • Alzheimer's Disease

Interventions

  • RO7568282Drug

    RO7568282 will be administered as specified in the protocol.

  • PlaceboDrug

    RO7568282 matching placebo will be administered as specified in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 72 in Clinical Dementia Rating, Sum of Boxes (CDR-SB)Time frame: From baseline up to Week 72

Locations

12 sites in 5 countries. Site status is shown where the registry gives one.

  • Alzheimer's Research and Treatment Center

    Stuart, Florida · Recruiting

  • Alzheimer?s Research and Treatment Center

    Wellington, Florida · Recruiting

  • Conquest Research, LLC

    Winter Park, Florida · Recruiting

  • Basil Clinical

    Laurelton, New York · Recruiting

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia · Recruiting

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia · Recruiting

  • Groupement Hospitalier Est - Hôpital Neurologique

    Bron, France · Recruiting

  • Gerontopole

    Toulouse, France · Recruiting

  • Klinikum rechts der Isar der TU München

    München, Germany · Recruiting

  • O?rodek Badawczo-Naukowo-Dydaktyczny Chorób Ot?piennych w ?cinawie

    Ścinawa, Poland · Recruiting

  • EUROMEDIS Sp z o o

    Szczecin, Poland · Recruiting

  • NeuroProtect

    Warsaw, Poland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.